Thus, these results suggest that apelin/APJ and exercise may prevent pathological cardiac hypertrophy by activating the PI3K/Akt/mTOR/p70S6K and PI3k-Akt-ERK1/2-p70S6K pathways. Here, APLNR is linked to cardiac hypertrophy.